We are pleased to inform you that GENEXI biotech accelerator arranges a special round of GEN Token Sale for KICKICO community.
The round started on September 10 at 18.00 GMT and will end on October 10. During the previous rounds, over 4,000,000,000 GEN tokens valued at $ 0.01 were sold.
GENEXI is an ambitious project with a strong team and a board of advisors, including Roel Wolfert, Anti Danilevski, Malcolm Tan, Oliver Bussmann and others.
Genexi combines the expertise of renowned specialists in the biotech industry to create a thriving ecosystem for pharmaceutical companies of different levels of operations from around the world.
GENEXI Platform is an innovative solution provided by the GENEXI Dev Team for the e-commerce market in order to support GENEXI Ecosystem development. The platform unites biotech producers, distributors, retailers and end-consumers in one blockchain solution based globally operating ecosystem.
Problems to be solved…
GENEXI believes that there are various problems on the current BioTech Markets, which need to be resolved, such as insufficient funding and expertise, poor quality assurance, substandard or falsified products.
GENEXI Team strives to tackle the aforementioned problem through the introduction of a comprehensive and transparent blockchain-based ecosystem.
Why use Blockchain?
- Blockchain provides transparency in the clinical research processes
- Blockchain ensures that the data supplied by the clinical research process is credible and immutable
- Blockchain smart-contracts allow for automation of the process and enable decentralized control for investors
Tremendous Growth Opportunities
According to GENEXI analysts, 2017 was a record year for biotech investments. VC funding for digital health accounted for nearly $4.5 billion which is approximately 109% up in comparison with 2016.
According to their estimates, the world biotechnology market value will cross $2 trillion in 2018 with 67% of manufacturers revenue coming from the sales of biotech and pharmaceutical products.
GENEXI expects the global biotech industry to register a stable annual growth of around 4.9% during the next 5 years.
Genexi has wide market perspectives, such as Whole Genome Scanning, Stem Cells, Gene Therapy, RNAi, MicroRNAs, Implantable sensors and others! Genexi Experts estimate that the global counterfeit drug market ranges from $65 to $180 billion
GENEXI has established partnership with leading research labs, institutes and scientists to select the most promising projects with the highest expected return rates:
Utilising the powers of the platform, a biotech producer can focus priorly on development and production, significantly cutting the costs of marketing and consulting, and attract multiple distributors without having to establish a wide range of products first.
Do not miss this opportunity! …and